Selective expression and significance of ACKR2 in lung aerocytes

Francesca Albano1,2, Valeria Mollica Poeta1,2, Lucia Zotti1,2

  • 1IRCCS Humanitas Research Hospital, Rozzano, Italy.

PubMed
Abstract

Insights

Targeting ACKR2 in lung aerocytes reduces cancer metastasis. Deleting ACKR2 from lung endothelial cells enhances T lymphocyte infiltration, hindering tumor spread.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Atypical chemokine receptor 2 (ACKR2) regulates inflammation by binding and degrading inflammatory CC chemokines.
  • Genetic absence of ACKR2 has been linked to increased tumor growth and protection against lung metastasis in different cancer models.
  • This study investigates ACKR2 expression and its role in lung metastasis.

Purpose of the Study:

  • To identify the specific cell types expressing ACKR2 in the lungs.
  • To determine the contribution of ACKR2 in different endothelial cells to lung metastasis.
  • To explore the impact of ACKR2 deletion on immune cell infiltration and metastasis.

Main Methods:

  • Generated inducible and conditional ACKR2 knockout mice with reporter genes for in vivo imaging, flow cytometry, and immunofluorescence.
  • Performed RNA sequencing on lung endothelial cells (ECs).
  • Utilized in vivo models of lung metastasis (melanoma, colorectal cancer) and acute lung injury (LPS).
  • Analyzed leukocyte infiltration using FACS and measured serum chemokine levels via multiplex ELISA.

Main Results:

  • ACKR2 is expressed by lymphatic endothelial cells (LECs) in most organs, but uniquely in lung blood endothelial cells (BECs) called aerocytes.
  • Selective deletion of ACKR2 from ECs (ACKR2ΔCdh5) protected against lung metastasis, unlike deletion from LECs (ACKR2ΔProx1).
  • Protection correlated with increased T lymphocyte infiltration in the lungs; enhanced T lymphocyte extravasation was observed in ACKR2-deleted ECs during lung injury.

Conclusions:

  • ACKR2 is selectively expressed by lung aerocytes, regulating leukocyte extravasation.
  • Targeting ACKR2 in lung vascular capillaries modulates chemokine availability.
  • Promoting T lymphocyte extravasation via ACKR2 targeting reduces lung metastasis.